Equities

Surmodics Inc

Surmodics Inc

Actions
Health CareMedical Equipment and Services
  • Price (EUR)34.80
  • Today's Change-0.20 / -0.57%
  • Shares traded--
  • 1 Year change+22.54%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
ASSETS
Cash And Short Term Investments404519
Total Receivables, Net232020
Total Inventory151512
Prepaid expenses2.866.046.76
Other current assets, total------
Total current assets818758
Property, plant & equipment, net252931
Goodwill, net454341
Intangibles, net242628
Long term investments----0
Note receivable - long term------
Other long term assets4.090.881.14
Total assets179186158
LIABILITIES
Accounts payable--2.993.14
Accrued expenses--1715
Notes payable/short-term debt--010.00
Current portion long-term debt/capital leases------
Other current liabilities, total214.384.16
Total current liabilities212432
Total long term debt30290
Total debt302910.00
Deferred income tax--2.002.03
Minority interest------
Other liabilities, total9.571016
Total liabilities606650
SHAREHOLDERS EQUITY
Common stock--0.710.70
Additional paid-in capital--3729
Retained earnings (accumulated deficit)--8789
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total119(4.76)(9.87)
Total equity119120108
Total liabilities & shareholders' equity179186158
Total common shares outstanding141414
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.